|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0858 - 0.1000|
|52 Week Range||0.0800 - 0.3145|
|Beta (3Y Monthly)||2.63|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 12, 2020 - Feb 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LAS VEGAS, NV, Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Digipath, Inc. (DIGP), is pleased to announce it has entered into a binding letter of intent for the acquisition of VSSL Enterprises Ltd. (“VSSL”), a British Columbia based cannabis genomics, plant sciences and consulting firm. The acquisition is expected to provide Digipath with a wealth of cannabis data, technology and intellectual property, including in excess of a thousand hemp and cannabis genotypes. The letter of intent provides for the acquisition of 100% of VSSL’s outstanding shares of capital stock for consideration consisting of six million shares of Digipath common stock and a cash payment of $200,000, and is subject to the execution of definitive agreements.
BOULDER, CO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Digipath, Inc. (DIGP), a leading independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that GroSciences, its wholly owned subsidiary, has successfully completed beta-testing of its “Tru-Hemp ID” kit. Under the 2018 Farm Bill that legalized hemp cultivation, hemp is defined as having less than 0.3% delta-9-THC by dry weight. As a result, compliance with the 2018 Farm Bill is usually determined by analyzing the THC content of a particular plant sample. Tru-Hemp ID offers a simpler method for determining the strain of a particular plant in the form of a genetic test. A full analysis of all data collected thus far using the Tru-Hemp ID kit that correlates the genetic outcome of samples with their actual THC content will be forthcoming.
BOULDER, Colo., Aug. 14, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially serve an enormous market by protecting cannabis plants against colonization by microorganisms. The testing has also shown that TERPO+ Broadspectrum acts as a treatment for the elimination of microbial bioburden on cannabis and hemp flowers.
Revenue Growth Comes as New Potential Revenue Lines Move into Beta Testing LAS VEGAS , Aug. 13, 2019 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service-oriented ...
LAS VEGAS, July 29, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that the Company's GroSciences subsidiary has made significant progress in developing its Tru-Hemp ID project, with commercial availability targeted for late 2019/early 2020. GroSciences is Digipath's wholly owned subsidiary which combines years of testing data and proprietary research to create "The Science to Succeed" for clients wanting expert guidance on formulations, identification, and more. As previously reported, Digipath, via GroSciences, has been developing a field testing kit for hemp, cannabis and other related products with a myriad of applications from law enforcement to growers.
PHOENIX, AZ / ACCESSWIRE / July 18, 2019 / The Stock Day Podcast welcomed Digipath, Inc. (DIGP) (“the Company”), a service-oriented independent testing laboratory, data analytics, and formulation firm focused on the developing cannabis and hemp markets. CEO and Founder, Todd Denkin, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company’s recent announcement of a field test for cannabis versus hemp identification for law enforcement.
LAS VEGAS, July 16, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP) ("DIGP" or the "Company"), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that Company CEO Todd Denkin was recently interviewed by CEO Roadshow with veteran journalist Mike Elliott. In this interview, Denkin discusses the Company's recent provisional patent applications involving terpene technology. "It's always a pleasure to sit down with Mr. Elliott, who is a true professional with a significant following," stated Todd Denkin, CEO, Digipath Inc. "In this interview we covered some of the more exciting things happening for Digipath and its shareholders.
The article, written by Forbes contributor Andre Bourque, addresses the messy nomenclature of the current cannabis market wherein an imprecise system of non-scientific names is used to identify and sell cannabis strains, or more accurately cannabis cultivars. Mr. Bourque refers to Dr. Orser and her colleague Dr. Philippe Henry's assertion that "the cannabis consumer patient often times has no real idea of the composition, consistency or comparability of the cannabis product that they purchase," in their previous peer-reviewed publication "Making Sense of Cannabis Strains through Chemometrics," in Cannabis Science & Technology.
This corresponds with the increased demand Digipath is experiencing for its governmentally required cannabis testing services in Nevada. In March alone, the State of Nevada reported record cannabis sales of just under $60 million. Recreational sales were $53.6 million, up $11.1 million from February, while medicinal sales were off by $800,000.
Revenues Continue to Rise Quarter Over Quarter LAS VEGAS , May 16, 2019 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service-oriented independent testing ...
LAS VEGAS, May 1, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that it has entered into an agreement to provide pharmaceutical grade analysis and testing services to One World Pharma (OTC Pink OWPC), a Colombian cannabis producer, using compliant lab equipment and processes under ISO:17025 or similar guidelines that will meet all necessary Colombian and international standards. The agreement gives Digipath its first commercial customer in Colombia. One World Pharma is licensed to produce and manufacture raw cannabis and hemp plant ingredients for both medical and industrial uses in Colombia with significant approvals and Colombian relationships in place, including permission to cultivate 13 different THC strains.
HOLLYWOOD, CA / ACCESSWIRE / April 19, 2019 / CBD business exploding, drinking water solutions, cannabis testing, gasoline prices; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...
LAS VEGAS, April 17, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), is pleased to provide an opportunity to hear more about the Company's ground breaking new field test for cannabis, hemp and CBD samples via an interview with Chief Science Officer Cindy Orser. Dr. Orser, PhD and Dr. Philippe Henry, PhD are the driving forces behind the development of the field test which has been created to provide relief and clarity for an array of uses where the type of cannabis product must be quickly and accurately determined using a portable methodology. High Times recently reported an instance where a fully-compliant hemp shipment was wrongfully seized due to a failure to properly identify the cargo. The DEA is now looking for a field test to avoid such problems.
HOLLYWOOD, CA / ACCESSWIRE / April 12, 2019 / Free wireless service, new hemp technology, water industry, hemp wine, acquisition mode, paycheck to paycheck; this week on MoneyTV with Donald Baillargeon. ...
HOLLYWOOD, CA / ACCESSWIRE / April 12, 2019 / Free wireless service, new hemp technology, water industry, hemp wine, acquisition mode, paycheck to paycheck; this week on MoneyTV with Donald Baillargeon. ...
Industry publications like High Times havealready reported how confusion and uncertainty by law enforcement in identifying what type of cannabis plant they are examining has led to arrests and confiscations for what was legal hemp. In late February, as Drs. Orser and Henry were putting the final touches on the joint provisional patent application, the United States Drug Enforcement Agency put out a Requestfor Proposal (RFP) for a field testing kit. A simple review of Digipath's patent application reads as if the DEA was reading their minds.
LAS VEGAS, April 9, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that in collaboration with VSSL of Kelowna, BC, has filed a provisional patent application for a Field Testing Kit that can quickly determine whether a plant sample is actually hemp, drug-type THC or drug-type CBD. Currently the only recourse for law enforcement to make a determination of what is being transported across state lines is lab based analytical testing of the mature plants for their THC content to come in under the 0.3% THC level. The Digipath-VSSL simple genetic field test will allow for a DNA-based assay to clearly designate if plant material at any stage of growth is industrial hemp or drug-type CBD and NOT drug-type THC.
Name your favorite celebrity? I bet they have a pot brand. Gone are the days of hawking wine and luxury goods to make an extra buck. The rise of cannabis has attracted movie stars, musicians, politicians, athletes, and people from many other backgrounds looking to put their stamp on the burgeoning industry. Many of the partnerships sprouting up between Hollywood and the cannabis industry are with publicly traded companies. As a result, some celebrities are getting wealthy off pot stocks. InvestorPlace - Stock Market News, Stock Advice & Trading TipsWho are they?Well, if you take a look at this list of 20 Celebrities Who Are Marijuana Enthusiasts, several are already involved in the cannabis industry. * 10 Medical Marijuana Stocks to Cure Your Portfolio I've taken some of the people on that list, added a few not mentioned, and created a list of five celebrities who could be in line for an outstanding payday should their pot stocks continue to move higher. Snoop Dogg, Canopy Growth (CGC)Source: Shutterstock When you think of celebrities and pot, Snoop would be on most people's list. The two go hand in hand. Snoop has been in a partnership with Canopy Growth (NYSE:CGC), Canada's largest cannabis company by market cap, since October 2016. Canopy's Tweed Shop online store is selling Snoop's Leafs by Snoop brand. To celebrate the occasion, Snoop threw a private party in Toronto for his new friends. Since then, Snoop's cannabis interests have taken off. In March 2018, Snoop's Casa Verde Capital raised $45 million in venture capital to invest in the cannabis industry. Recently, the musician connected his TV pal Martha Stewart with Canopy Growth CEO Bruce Linton. Stewart is working with the company to create a line of hemp-derived CBD pet products. "I think it's a starting spot that was comfortable for everyone involved. We have the science and she's a lifelong dog, horse, animal person," Linton said in early March. "This just seemed like a really balanced and suitable starting point."Snoop and Martha. Together again. Seth Rogen, Canopy Growth (CGC)Source: WikipediaThe Canopy Growth list of celebrity partners got a little longer March 29 when Canadian actor and comedian Seth Rogen and screenwriter Evan Goldberg announced a partnership with the company. The duo's brand is called Houseplant. After working together on the film Pineapple Express, Rogen and Goldberg created the Toronto-based company along with some other friends and colleagues. "We could not be more passionate about this company and are dedicated to doing everything the right way," stated Rogen. "It is extremely important to us to treat cannabis with the reverence it deserves. What a time!"Although no specific financial details were given, Canopy has acquired 25% of Houseplant, invested some working capital, and will provide the facilities to grow. For Canopy's part, it was careful to point out that its new partners aren't just figurehead, but actual business owners who've spent the past five years preparing to launch the company. * 5 Cannabis Stocks Set to Skyrocket -- According to Wall Street's Top Analysts Its first product is Houseplant Sativa. It will initially be sold in B.C., rolling out across Canada after that. Pre-rolled joints and softgels will follow later in 2019. All products will be grown and produced at Canopy's facilities in Smith's Falls, Ontario, where Canopy is based. Trailer Park Boys, Organigram (OGRMF)Source: Shutterstock I don't know how many Americans are familiar with the Trailer Park Boys: Ricky, Bubbles, and Julian. However, in Canada, their show ran on an off for close to 20 years. A crazy show that never was expected to go anywhere, the Trailer Park Boys have turned into a global following. It's for this reason that New Brunswick-based cannabis company OrganiGram (OTCMKTS:OGRMF) partnered with the Nova Scotia trio in November 2016 to produce Trailer Park Buds recreational pot at the company's facility in Moncton. "This relationship solidifies one of our strategic building blocks as we plan for the legalization of recreational use in Canada. The team at Trailer Park Boys have an aligned vision to develop a National brand with our assistance and we're incredibly excited at how the partnership will come to life," Ray Gracewood, Chief Commercial Officer at OrganiGram, said at the time. The interesting piece of this partnership is that the marketing rules surrounding recreational pot in Canada are so stringent, Trailer Park Buds almost didn't pass the sniff test. Under regulations, endorsements, sponsorships, testimonials aren't allowed. Neither are promotions appealing to youth or associating with a particular lifestyle. Luckily, almost two years of work didn't end up on the cutting room floor when recreational pot became legal last October. OtganiGram's Gracewood commented at the time of legalization that there was enough of a distance between the Trailer Park Boys and Trailer Park Buds to get the green light from Health Canada. That's excellent news for shareholders. Gene Simmons, Invictus MD Strategies (IVITF)Source: FlickrI wanna rock and roll all night and party every day. The words of Kiss' most successful song roll off the tongue keeping lead singer Gene Simmons in a very comfortable California lifestyle. A natural marketer and businessman, Simmons sensed Cannabis was going to be big and inserted himself into the industry by agreeing to become Invictus MD Strategies' (OTCMKTS:IVITF) chief evangelist in March 2018. "Three years ago, I was dismissive, arrogant and uninformed about medical cannabis and thought the whole notion of its medical uses as so much smoke and mirrors," Simmons said in July 2018. "But over the last few years, I've started to see the tremendous new information that scientists and researchers have been telling us about the incredible uses for this humble plant that just grows there in the ground. I'm incredibly bullish on the product and, particularly, on this company."Unfortunately, while Simmons was high on Invictus, investors don't appear to be high on Simmons or the company. Its stock is down 34% since Invictus and the Kiss frontman announced their relationship. * Critical Levels to Watch in 3 Marijuana Stocks However, Invictus paid him $2.5 million in cash, issued 2.6 million shares, with another four million shares to be issued in the future, so he's got $10 million reasons to get its stock price over $1. Tragically Hip, Hexo (HEXO)Source: Shutterstock The Tragically Hip is one of Canada's favorite bands. Its lead singer, Gord Downie, died of cancer at the age of 53 in October 2017. The band first partnered with Newstrike Brands (OTCMKTS:NWKRF) in May 2017 before Downie passed away. Not only did the members of the band invest in Newstrike, but they also agreed to partner with Newstrike in preparation of the legalization of cannabis in Canada. The band did its due diligence at the time and felt Newstrike had all the right ingredients from a scientific perspective to feel comfortable attaching the Tragically Hip name to the company. More than two years later, Quebec-based Hexo (NASDAQ:HEXO) swept in, agreeing to buy Newstrike for $260 million in HEXO stock. Each Newstrike shareholder will get 0.06332 of a HEXO share for every Newstrike share. Hexo acquired Newstrike in part because of the Tragically Hip but also because the company has a partnership with Toronto food company Neal Brothers to produce specialty edibles. That will be very popular with Canadians. Not sure how many shares the Tragically Hip have in Newstrike, but if I were them, I'd keep the HEXO shares they get in the takeover because Hexo's other deal with Molson Coors (NYSE:TAP) looks to be a good one. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Stocks That Would Be Hurt By a Mexico/U.S. Border Closure * 7 A-Rated Healthcare Stocks for Industry Expansion * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever Compare Brokers The post 5 Celebrities Making Money Off Pot Stocks appeared first on InvestorPlace.
SPRING HOPE, NC, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP) is pleased to announce the huge success of its 1st Hemp University educational seminar on the west coast, in Ashland, Oregon. Held this past weekend (Saturday, March 23, 2019) at Southern Oregon University, the sold-out event provided attendees with a full day of networking, education, and support. As a global leader in the industrial hemp industry with bi-coastal processing centers including a state of the art hemp processing center in Medford, Oregon, the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, one of Hemp, Inc.’s missions has been to revive family farms and small businesses in the hemp industry.
SPRING HOPE, NC, March 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, announced today Hemp, Inc. CEO, Bruce Perlowin accepted The First Annual Hemp Awards recognition as “Man of the Year” for 2018, at the ASD Market Week show in Las Vegas. The award comes from his outstanding achievement in ‘The American Hemp Industry’. The award demonstrated the amount of increased recognition the hemp industry is continuing to receive and reflects the demand for leaders within this space is recognized.
LAS VEGAS, March 21, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that its CEO and Founder Todd Denkin and its Chief Science Officer Dr. Cindy Orser have been asked to present at the Hemp University symposium March 23, 2019 on the campus of Southern Oregon University. The event is hosted by Hemp, Inc. (HEMP) and brings together some of the leading minds in hemp to educate, support and build community for hemp farmers and entrepreneurs.
LAS VEGAS, March 19, 2019 /PRNewswire/ -- Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and hemp markets, is pleased to announce that it is the featured company in the most recent edition of CANNAINVESTOR Magazine, with comprehensive coverage of the Company's business model and accomplishments. "CANNAINVESTOR Magazine presents us with a tremendous opportunity to share the Digipath story with an ideal audience of investors who have a proven interest in better cannabis public companies," stated Todd Denkin, CEO, Digipath, Inc. "It is quite literally the ideal demographic and I strongly encourage any current or prospective investor to read through the presentation. Digipath, Inc. supports the cannabis industry's best practices for reliable testing, data acquisition, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry. Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers, and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client's products through analysis, research, development, and standardization.
SPRING HOPE, NC, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, announced today the first Oregon-based Hemp University educational seminar will take place at Southern Oregon University in Ashland, on March 23, 2019. This full day of education, support and networking will be located just 13 miles from Hemp, Inc.’s sophisticated Local Processing Center in Medford, Oregon, which focuses on hemp flower harvesting, drying, curing, chucking, trimming, storing and post-processing for cannabidiol (CBD).
HOLLYWOOD, CA / ACCESSWIRE / March 15, 2019 / Disrupting the water industry, battling the opioid crisis, terpenes' many uses, high-end CBD products, NASDAQ application, audio PRs,, socialism vs. capitalism ...
Terpenes, a name we suspect you will start hearing more and more often, are the major components of plant derived essential oils and have been used by humans for thousands of years (think aromatherapy). Terpenes are another category of chemicals made by most plants, including cannabis where they play the major factor in how THC or CBD affect a person withstandalone activity of their own. The first patent announcement gives Digipath a potential presence in the emerging cannabis beverage market.